nodes	percent_of_prediction	percent_of_DWPC	metapath
Framycetin—CXCR4—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.0395	0.0443	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.0395	0.0443	CbGpPWpGaD
Framycetin—CXCR4—forebrain—narcolepsy	0.0391	0.357	CbGeAlD
Framycetin—CXCR4—Peptide ligand-binding receptors—HCRT—narcolepsy	0.0324	0.0364	CbGpPWpGaD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0309	0.0347	CbGpPWpGaD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0309	0.0347	CbGpPWpGaD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0299	0.0335	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—PENK—narcolepsy	0.0289	0.0325	CbGpPWpGaD
Framycetin—CXCR4—medulla oblongata—narcolepsy	0.0282	0.258	CbGeAlD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0265	0.0297	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0265	0.0297	CbGpPWpGaD
Framycetin—CXCR4—midbrain—narcolepsy	0.0258	0.236	CbGeAlD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0256	0.0287	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—TRH—narcolepsy	0.0246	0.0276	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—PENK—narcolepsy	0.0244	0.0274	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0218	0.0244	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—HCRTR1—narcolepsy	0.0202	0.0227	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—HCRTR2—narcolepsy	0.0202	0.0227	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—P2RY11—narcolepsy	0.0195	0.0219	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0194	0.0218	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—HLA-DRB1—narcolepsy	0.0188	0.0211	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—HRH3—narcolepsy	0.0182	0.0204	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—TAC1—narcolepsy	0.0179	0.0201	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—NPS—narcolepsy	0.0179	0.0201	CbGpPWpGaD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.0169	0.0189	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—HCRT—narcolepsy	0.0166	0.0186	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.0165	0.0185	CbGpPWpGaD
Framycetin—CXCR4—brain—narcolepsy	0.0162	0.148	CbGeAlD
Framycetin—CXCR4—GPCR ligand binding—PENK—narcolepsy	0.0148	0.0166	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.0145	0.0162	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—TRH—narcolepsy	0.0126	0.0141	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.012	0.0135	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.012	0.0135	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—HCRTR1—narcolepsy	0.0114	0.0128	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—HCRTR2—narcolepsy	0.0114	0.0128	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—P2RY11—narcolepsy	0.011	0.0124	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—HRH3—narcolepsy	0.011	0.0124	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—HCRTR1—narcolepsy	0.0104	0.0116	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—HCRTR2—narcolepsy	0.0104	0.0116	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—P2RY11—narcolepsy	0.01	0.0112	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—HCRT—narcolepsy	0.00936	0.0105	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—TAC1—narcolepsy	0.00912	0.0102	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—NPS—narcolepsy	0.00912	0.0102	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—HCRT—narcolepsy	0.0085	0.00955	CbGpPWpGaD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00841	0.00945	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PENK—narcolepsy	0.00835	0.00937	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PENK—narcolepsy	0.00758	0.00851	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00721	0.00809	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—TRH—narcolepsy	0.0071	0.00797	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—TRH—narcolepsy	0.00644	0.00724	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—HRH3—narcolepsy	0.00622	0.00699	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HCRTR2—narcolepsy	0.00612	0.00687	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HCRTR1—narcolepsy	0.00612	0.00687	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—P2RY11—narcolepsy	0.00591	0.00663	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—HRH3—narcolepsy	0.00565	0.00634	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—HTR2A—narcolepsy	0.00549	0.00616	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—TAC1—narcolepsy	0.00516	0.00579	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—NPS—narcolepsy	0.00516	0.00579	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HCRT—narcolepsy	0.00502	0.00564	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—TAC1—narcolepsy	0.00468	0.00526	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—NPS—narcolepsy	0.00468	0.00526	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PENK—narcolepsy	0.00448	0.00503	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TRH—narcolepsy	0.00381	0.00427	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HRH3—narcolepsy	0.00334	0.00375	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—HTR2A—narcolepsy	0.0031	0.00348	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—HTR2A—narcolepsy	0.00282	0.00316	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NPS—narcolepsy	0.00277	0.00311	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TAC1—narcolepsy	0.00277	0.00311	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HTR2A—narcolepsy	0.00166	0.00187	CbGpPWpGaD
